SiteRx
SiteRx is the first virtual clinical trial site focused on building the bridge between clinical research and clinical care SiteRx Team: Manoj Pooleery Seth Goodman
Read MoreAvoMD
AvoMD is a mobile clinical application and content platform where clinicians are guided through the process of diagnosis and treatment at the point of care, with relevant portions of the…
Read MoreCapCell Biologics
CapCell Biologics is treating rare diseases with implants composed of engineered cells in a protective mesh capsule. CapCell Biologics Team: Ben Young Jon Zaikowski
Read MoreEpiBone, Inc.
We grow personalized living bone grafts in our lab, from patients own cells in the size and shape they need. EpiBone Team: Nina Tandon EpiBone has been with The Next…
Read MoreVivPure
My technology is the development of antibacterial metal surfaces and implementation into the food industry. Pure Nano provides a process for coating metal machinery which comes in contact with food…
Read MoreBrainFUS
BrainFUS is a patent ultrasound medical system to treat brain disease by disrupting the blood-brain barrier and assisting drug delivery noninvasively. Team: Shih-Ying Wu, PhD
Read MoreKures, inc.
I am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression. Kures, Inc. Team: Andrew Kruegel
Read MoreCoherence Medical Technologies
Optical Coherence Tomography (OCT) guided interventional bioptome catheter and diagnostic system for the real-time diagnosis of cardiac diseases. Coherence Team: David Tsay
Read MoreSavvy Cooperative
Savvy Cooperative is the Match.com for patient insights, where professionals can connect with targeted patients to gain the insights they need to build better products and services. Team: Jen Horonjeff,…
Read MoreFET-Diagnostics
We combine nano-scale device and circuit design with biochemistry to explore more efficient strategies for fast diagnosis of infectious diseases at the point of care. FET-Diagnostics Team: Scott Trocchia
Read More